• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC. CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC. CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problems Fluid/Blood Leak (1250); Device Displays Incorrect Message (2591)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/28/2020
Event Type  malfunction  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the reportable malfunction tubing leak.Since this reportable malfunction is only associated with the kit, this mdr will only be against the kit.A batch record review for kit lot h250 was conducted.There were no non-conformances associated with this lot.This lot met all release requirements.A review of kit lot h250 shows no trends.Trends were reviewed for complaint categories, alarm #52: collect line air detected and tubing leak.No trends were detected for each complaint category.This assessment is based on the information available at the time of the investigation.At the time of this report, the analysis of the returned photographs is still in progress.A supplemental report will be filed when the analysis is complete.(b)(4).
 
Event Description
The customer contacted mallinckrodt to report they experienced a tubing leak with their cellex photopheresis kit ("kit") during an extracorporeal photopheresis (ecp) treatment.The customer reported at the beginning of the treatment they received an alarm #52: collect line air detected alarm and noted air in the collect line.The customer reported they observed blood leaking from the needle-free injection port located on the kit's collect line.The customer aborted the ecp treatment and did not return residual blood to the patient.The customer reported the patient was safe and successfully completed a new treatment after.The customer returned photographs for investigation.
 
Manufacturer Narrative
The complaint kit with smart card and photographs were returned for investigation.A review of the smart card data verified that blood collection began in double needle mode and an alarm #52: collect line air detected was received before the operator aborted the treatment.The treatment was aborted after 21 ml of whole blood had been processed.The customer provided photograph verifies the tubing leak as blood is seen leaking from the needle-free port on the collect line.Examination of the needle-free port on the collect line showed that the blue insert in the middle of the port was oval rather than circular.The collect line and anticoagulant line were pressure tested to check for leaks and a leak was verified at the needle-free port on the collect line.A material trace of the components used to build lot h250 did not find any non-conformances.A device history record review did not identify any related non-conformances, deviations or equipment maintenance events.This kit lot had passed all lot release testing.An inspection was performed on 33 master retains for finished kits with the same needle-free port lot number, and no issues with the needle-free ports were found.The cellex kit manufacturing process has been updated to include a visual inspection of all needle-free ports to ensure they are circular in shape and exhibit no visible damage.The reported tubing leak was most likely due to the damaged needle-free port.However, the source of needle-free port damage could not be identified through this investigation.No further action is required at this time.This investigation is now complete.(b)(4).14-may-2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS, INC.
bedminster NJ 07921
MDR Report Key9759738
MDR Text Key198753548
Report Number2523595-2020-00027
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 05/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/01/2021
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCLXECP
Device Lot NumberH250
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/02/2020
Initial Date Manufacturer Received 01/28/2020
Initial Date FDA Received02/26/2020
Supplement Dates Manufacturer Received05/01/2020
Supplement Dates FDA Received05/14/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-